About
Addiction treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
1
As Collaborator
5
Total Enrollment
586
By Phase
NA: 5PHASE3: 1
By Status
COMPLETED: 3RECRUITING: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05967715Collaborator
Exercise Training Influences Gut Microbiota and Cardiovascular Health Through Inflammation Control in Adult Hypertensive Population: the MicroFit Study
NARecruiting
75 participants
Started: Apr 3, 2023 · Completed: Apr 2, 2026
NCT04101227Lead Sponsor
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
PHASE3Completed
302 participants
Started: Feb 1, 2020 · Completed: Mar 18, 2022
NCT03704727Collaborator
The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy
NACompleted
5 participants
Started: Jul 1, 2018 · Completed: Feb 1, 2019
NCT04256785Collaborator
Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia
NACompleted
110 participants
Started: May 11, 2018 · Completed: May 31, 2020
NCT03415711Collaborator
PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
NATerminated
14 participants
Started: Apr 28, 2017 · Completed: Apr 24, 2019
Locations (1)
Headquarters
Glen Allen, VA, United States
Map
Loading map...